Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2000-01-07
2002-05-21
Jones, W. Gary (Department: 1655)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
06391555
ABSTRACT:
REFERENCE TO A “MICROFICHE APPENDIX”
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to avian leukosis/sarcoma virus (ALSV)-induced cancer. More particularly, the present invention relates to a method for the detection of the propensity to develop ALSV-induced cancer, and a method to diagnose cancer induced by both exogenous and endogenous ALSV.
2. General Background of the Invention
The following references are incorporated herein by reference:
Johnson, Eric S., Lila Overby, and Richard Philpot, “Detection of Antibodies to Avian Leukosis/Sarcoma Viruses and Reticuloendotheliosis Viruses in Humans by Western Blot Assay”, Cancer Detection and Prevention, 19(6):472-486 (1995);
Johnson, Eric S., Lori Nicholson, and David Durack, “Detection of Antibodies to Avian Leukosis/Sarcoma Viruses (ALSV) and Reticuloendotheliosis Viruses (REV) in Humans by ELISA”, Cancer Detention and Prevention, 19(5):394-404 (1995);
U.S. Pat. Nos. 5,710,010; 5,716,832; 5,703,055; 5,672,485; 5,591,624; 5,258,299; 5,049,502; 5,028,540; H001065; and
all references mentioned herein.
BRIEF SUMMARY OF THE INVENTION
The method of the present invention solves the problems of detecting, diagnosing, and treating ALSV-induced cancer in a simple and straightforward manner. What is provided is a method of 1) testing a subject for a propensity to develop, 2) diagnosing, and 3) treating ALSV-induced cancer, comprising obtaining a sample of cells or tissue from the subject, processing the cell/tissue sample to isolate DNA from the sample, and examining the DNA isolated from the sample to detect the presence of the ALSV LTR. This sample can be, but is not limited to, cells, tissue, or a tumor. The DNA can be examined using a PCR-based assay with the aid of at least one primer set from the group consisting of: AL1D (SEQ ID NO:1)/AL2B (SEQ ID NO:2), nprA181 (SEQ ID NO:3)
prA308 (SEQ ID NO:4), nprA271(SEQ ID NO:5)/AL2B (SEQ ID NO:2), RAVO-1(SEQ ID NO:6)/RAVO-2(SEQ ID NO:7), AL1D (SEQ ID NO:1)/A-Au(SEQ ID NO:13), S-Au(SEQ ID NO:12)/A-Au(SEQ ID NO:13), and nprA271(SEQ ID NO:5)/A-Au(SEQ ID NO: 13), Sn271J (SEQ ID NO:14)/A-AuJ (SEQ ID NO:15).
REFERENCES:
Johnson et al. Cancer Detection and Prevention, vol. 19, 1995, pp. 394-404.*
Johnson, Cancer Detection and Prevention, vol. 18, pp. 9-30, 1994.*
Kung et al, From: Avian Leukosis, ed: G.F.Deboer, Marinus Nijhoff publishing, pp. 77-99, 1987.
Garvey, Smith, Nehrbass & Doody, L.L.C.
Jones W. Gary
Souaya Jehanne
LandOfFree
Assay for the detection of avian leukosis/sarcoma viruses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for the detection of avian leukosis/sarcoma viruses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for the detection of avian leukosis/sarcoma viruses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2841259